Scope of Application

The Antimicrobial Resistance Quest 2020 is inviting applications in the AMR domain spanning:

• Non-traditional therapeutics including the indirect acting small molecules (virulence, potentiators, BLI combinations, etc), Direct- and indirect-acting large molecules (peptides, etc.), phage, microbiome, nucleic acid, anti-sense, Drug conjugates (ADC, other dual acting drug conjugates)
• Preventatives including vaccines, preventative antibodies and fragments, and microbiome products.
• Diagnostics including devices which can diagnose ID/AST of pathogens
• Direct acting small molecule therapeutics including new classes of drugs or new targets only

* All applications need to be related to development of products, not basic research

For more information click here.